Title: Tannous BA, et al. Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs. J Natl Cancer Inst. 2013 Sep 4;105(17):1322-31.
1627710-50-2 | LJH685 | AA00ABPV | MFCD29924738
17113-33-6 | 2-Phenylfuran | AA00AC2E | MFCD00234628
193417-26-4 | N-[3-(TRIETHOXYSILYL)PROPYL]-2-CARBOMETHOXYAZIRIDINE | AA00ACC1 | MFCD01320975
15291-66-4 | 3,5,7-Trimethyladamantane-1-carboxylic acid | AA00ACQU | MFCD00187581
185946-05-8 | 3-Fluoro-4-(methylsulfonyl)benzonitrile | AA00ACWQ | MFCD12922838
183320-19-6 | 7-O-DesMethoxy-7-O-chloroethyl Erlotinib Hydrochloride | AA00AD3D
152404-52-9 | 4-HYDROXYBENZALDEHYDE-CARBONYL-13C | AA00AD9T | MFCD00190323
173074-85-6 | 2-(5-TETRADECENYL)CYCLOBUTANONE | AA00ADGB | MFCD01863118
175481-39-7 | Desacetyl DesMethyl LacosaMide | AA00ADPI | MFCD22116264
17874-34-9 | 8-tert-butyl-4,6-dimethyl-2-benzopyrone | AA00ADX8 | MFCD01742003